InnoCare Pharma Inc. - Significant Ownership

Signature - Title
/s/ Jisong Cui - By Jisong Cui, Chairperson and CEO
Location
Princeton, NJ
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by InnoCare Pharma Inc..

Significant Ownership of InnoCare Pharma Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ZBIO Zenas BioPharma, Inc. Common Stock, par value $0.0001 per share 9.4% $111M 5M InnoCare Pharma Inc. Oct 7, 2025

Schedules 13D/G Reported by InnoCare Pharma Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.